Confirmatory Biopsy for the Assessment of Prostate Cancer in Men Considering Active Surveillance: Reference Centre Experience

ecancermedicalscience - United Kingdom
doi 10.3332/ecancer.2016.633
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ecancer Global Foundation

Related search

Can Confirmatory Biopsy Be Omitted in Patients With Prostate Cancer Favorable Diagnostic Features on Active Surveillance?

Journal of Urology
Urology
2016English

Targeted Prostate Biopsy to Select Men for Active Surveillance: Do the Epstein Criteria Still Apply?

Journal of Urology
Urology
2014English

Active Surveillance for Prostate Cancer

International Journal of Urology
Urology
2015English

Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary–Early Detection Research Network Active Surveillance Biopsy Risk Calculator

European Urology
Urology
2015English

Pd20-11 17-Gene Genomic Prostate Score Can Accurately Determine the Need for Confirmatory Biopsy in Patients Electing Active Surveillance

Journal of Urology
Urology
2018English

Longitudinal Assessment of Urinary PCA3 for Predicting Prostate Cancer Grade Reclassification in Favorable-Risk Men During Active Surveillance

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2017English

Pd28-10 Multiparametric-Mri Prior to Repeat Biopsy for Active Surveillance Can Identify Men With High-Risk Prostate Cancer

Journal of Urology
Urology
2017English

Active Surveillance in Prostate Cancer

Üroonkoloji Bülteni
2017English

Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy